1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Number 09861630

US 09861630 B1
Application Number15674043
Publication NumberUS 20170360777 A1
Pendency5 months, 2 days
Filled DateAug 10, 2017
Priority DateJun 16, 2006
Publication DateDec 21, 2017
Expiration DateJun 15, 2026
Inventor/ApplicantsAndre Faldt
Rene Holm
Heidi Lopez de Diego
André Faldt
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
H. Lundbeck As
Current
H. Lundbeck As
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.